Treatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs
- 1 June 2011
- journal article
- review article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 105 (6), 818-827
- https://doi.org/10.1016/j.rmed.2010.12.018
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertensionRespiratory Medicine, 2009
- Updated Clinical Classification of Pulmonary HypertensionJournal of the American College of Cardiology, 2009
- Diagnosis and Assessment of Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2009
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary HypertensionJournal of the American College of Cardiology, 2009
- Evidence-Based Pharmacologic Management of Pulmonary Arterial HypertensionClinical Therapeutics, 2007
- An evidence-based approach to the management of pulmonary arterial hypertensionCurrent Opinion in Cardiology, 2006
- Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Lipid Mediator Dysregulation in Primary Pulmonary HypertensionChest, 1998
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991